Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. With an overall survival rate of around 13%, it’s also one of the deadliest cancers. One reason for this is that ...
Indiana University School of Medicine scientists have identified a new way to weaken pancreatic cancer's defenses by targeting two key proteins that help the deadly disease resist treatment. The study ...
Pancreatic cancer is one of the deadliest forms of cancer, with a five-year survival rate of only 13%. It is known for being ...
Scientists at the Indiana University School of Medicine have helped to discover that blocking two key proteins, Ref-1 and ...
Zuen Ren, Huizhi Liang, Phillip M. Galbo Jr, Malindrie Dharmaratne, Ameya S. Kulkarni, Atefeh Taherian Fard, Marie Louise Aoun, Nuria Martinez-Lopez, Kimita Suyama ...
A monocyte mitochondrial superoxide cutoff accurately stratified short-term survival risk in hepatocellular carcinoma.
A new Nature study suggests that the glucose–fructose blend typical of sodas and juices fuels colorectal cancer metastasis ...
Dr Ramona Clemen, research group leader at the Leibniz Institute for Plasma Science and Technology (INP), has been awarded the prestigious ERC Starting Grant by the European Research Council (ERC).
New research uncovers link between two key proteins that help pancreatic cancer resist treatment, opening the door to more effective therapies for aggressive cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback